Skip to main
EHC
EHC logo

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 57%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health Corp has demonstrated a positive trajectory in its revenue guidance, with the high-end projections for 2024 increasing from $1.065 billion to $1.090 billion, reflecting confidence in its growth outlook. Additionally, the firm's guidance for 2023 also saw an upward revision from $910 million to $950 million, indicating strong operational performance. The company's strategic shift towards a growing Medicare Advantage payer mix, which has risen from approximately 9.2% in 2018 to about 16.5% in 1Q25, further highlights its competitive positioning and supports sustained growth in rehabilitative services.

Bears say

Encompass Health Corp faces significant risks related to its de novo and joint venture strategies, particularly with rising costs associated with facility construction and labor acquisition due to tariff uncertainties and competitive markets. These factors may hinder the company's ability to effectively staff new facilities, which is crucial for achieving mature operating levels. As a result, potential disruptions in staffing could adversely affect the overall earnings profile of the enterprise.

Encompass Health (EHC) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 57% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Buy based on their latest research and market trends.

According to 7 analysts, Encompass Health (EHC) has a Buy consensus rating as of Oct 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $139.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $139.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.